跳至主要内容
临床试验/IRCT201102015444N2
IRCT201102015444N2已完成2 期

Evaluation of the effect of letrozole on symptomatic uterine leiomyomas

Vice chancellor for Research of Kashan University of Medical Sciences0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20 years 至 51 years(—)
性别
Female

入选标准

  • Inclusion criteria : pre menopause patients who have symptomatic liomyomatos equivalent or larger than 3 cm. Exclusion criteria: patients who have received hormonal therapy; patients who have severe medical disorders; patients who have surgical treatment of myoma.

排除标准

  • 未提供

研究者

发起方
Vice chancellor for Research of Kashan University of Medical Sciences

相似试验